165 related articles for article (PubMed ID: 36471225)
1. Claudin-6 enhances the malignant progression of gestational trophoblastic neoplasm by promoting proliferation and metastasis.
Wu Q; Peng M; Lv C; Chen L; Mao X; Lin T; Sun P; Wang Y
Clin Transl Oncol; 2023 Apr; 25(4):1114-1123. PubMed ID: 36471225
[TBL] [Abstract][Full Text] [Related]
2. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
[TBL] [Abstract][Full Text] [Related]
3. Identification of microRNA signature in the progression of gestational trophoblastic disease.
Zhao JR; Cheng WW; Wang YX; Cai M; Wu WB; Zhang HJ
Cell Death Dis; 2018 Jan; 9(2):94. PubMed ID: 29367697
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of PDCD4 by deSUMOylation associates with the progression of gestational trophoblastic disease.
Wang YX; Cui L; Wu WB; Quinn MJ; Menon R; Zhao JR; Zhang HJ
Placenta; 2022 Dec; 130():17-24. PubMed ID: 36370491
[TBL] [Abstract][Full Text] [Related]
5. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
6. Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasion.
Rumer KK; Post MD; Larivee RS; Zink M; Uyenishi J; Kramer A; Teoh D; Bogart K; Winn VD
Endocr Relat Cancer; 2012 Dec; 19(6):827-40. PubMed ID: 23089140
[TBL] [Abstract][Full Text] [Related]
7. Surgery including fertility-sparing treatment of GTD.
Ngu SF; Ngan HYS
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():97-108. PubMed ID: 33127305
[TBL] [Abstract][Full Text] [Related]
8. Expression pattern Nanog is associated with the development of gestational trophoblastic neoplasia in Chinese women from Fujian province: a case-control study.
Wu Q; Chen L; Song Y; Zhu J; Chen Y; Sun P
Gynecol Endocrinol; 2021 Feb; 37(2):108-112. PubMed ID: 32584203
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of maspin and mutant p53 are associated with the development of gestational trophoblastic neoplasia.
Sun P; Wu Q; Ruan G; Zheng X; Song Y; Zhun J; Wu L; Gotlieb WH
Oncol Lett; 2016 Nov; 12(5):3135-3142. PubMed ID: 27899973
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of SALL4 in CTCs derived from hydatidiform moles and gestational trophoblastic neoplasms.
Xu D; Feng F; Pei Y; Zhang Y; Wu Y; Guo Y; Cui W
Am J Reprod Immunol; 2020 May; 83(5):e13233. PubMed ID: 32187420
[TBL] [Abstract][Full Text] [Related]
11. Claudin-6 is a single prognostic marker and functions as a tumor-promoting gene in a subgroup of intestinal type gastric cancer.
Kohmoto T; Masuda K; Shoda K; Takahashi R; Ujiro S; Tange S; Ichikawa D; Otsuji E; Imoto I
Gastric Cancer; 2020 May; 23(3):403-417. PubMed ID: 31654186
[TBL] [Abstract][Full Text] [Related]
12. FBI-1 Is Overexpressed in Gestational Trophoblastic Disease and Promotes Tumor Growth and Cell Aggressiveness of Choriocarcinoma via PI3K/Akt Signaling.
Mak VC; Wong OG; Siu MK; Wong ES; Ng WY; Wong RW; Chan KK; Ngan HY; Cheung AN
Am J Pathol; 2015 Jul; 185(7):2038-48. PubMed ID: 26093985
[TBL] [Abstract][Full Text] [Related]
13. N-linked α2,6-sialylation of integrin β1 by the sialyltransferase ST6Gal1 promotes cell proliferation and stemness in gestational trophoblastic disease.
Liu J; Dong X; Xie R; Tang Y; Thomas AM; Li S; Liu S; Yu M; Qin H
Placenta; 2024 Apr; 149():18-28. PubMed ID: 38490094
[TBL] [Abstract][Full Text] [Related]
14. A 10-Year Clinical Experience of Gestational Trophoblastic Disease at Rajavithi Hospital, 2001-2010.
Yanaranop M; Potikul C; Tuipae S
J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S17-27. PubMed ID: 27266212
[TBL] [Abstract][Full Text] [Related]
15. Gestational Trophoblastic Neoplasia From Genetically Confirmed Hydatidiform Moles: Prospective Observational Cohort Study.
Usui H; Qu J; Sato A; Pan Z; Mitsuhashi A; Matsui H; Shozu M
Int J Gynecol Cancer; 2018 Nov; 28(9):1772-1780. PubMed ID: 30358702
[TBL] [Abstract][Full Text] [Related]
16. Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma.
Zhang HJ; Siu MK; Yeung MC; Jiang LL; Mak VC; Ngan HY; Wong OG; Zhang HQ; Cheung AN
Carcinogenesis; 2011 May; 32(5):765-71. PubMed ID: 21325635
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features of gestational trophoblastic neoplasia in the Limpopo Province, South Africa.
van Bogaert LJ
Int J Gynecol Cancer; 2013 Mar; 23(3):583-5. PubMed ID: 23429489
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy.
Song P; Li Y; Dong Y; Liang Y; Qu H; Qi D; Lu Y; Jin X; Guo Y; Jia Y; Wang X; Xu W; Quan C
J Exp Clin Cancer Res; 2019 Aug; 38(1):354. PubMed ID: 31412908
[TBL] [Abstract][Full Text] [Related]
19. Epidemiologic study on gestational trophoblastic diseases in Japan.
Yamamoto E; Nishino K; Niimi K; Ino K
J Gynecol Oncol; 2022 Nov; 33(6):e72. PubMed ID: 36047375
[TBL] [Abstract][Full Text] [Related]
20. p21-Activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease.
Siu MK; Yeung MC; Zhang H; Kong DS; Ho JW; Ngan HY; Chan DC; Cheung AN
Am J Pathol; 2010 Jun; 176(6):3015-22. PubMed ID: 20413688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
